+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Levetiracetam"

From
From
Epilepsy Drugs - Global Strategic Business Report - Product Thumbnail Image

Epilepsy Drugs - Global Strategic Business Report

  • Report
  • April 2025
  • 93 Pages
  • Global
From
Anticonvulsants Market Report 2025 - Product Thumbnail Image

Anticonvulsants Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Grand Mal Seizure Treatment Market Report 2025 - Product Thumbnail Image

Grand Mal Seizure Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
From
From
From
From
From
Research Report on China's Levetiracetam Market, 2021-2025 - Product Thumbnail Image

Research Report on China's Levetiracetam Market, 2021-2025

  • Report
  • September 2021
  • 40 Pages
  • China
From
From
From
Loading Indicator

Levetiracetam is a medication used to treat epilepsy and other seizure disorders. It is a type of anticonvulsant drug, which works by reducing the abnormal electrical activity in the brain that causes seizures. Levetiracetam is used to treat partial onset seizures, myoclonic seizures, and primary generalized tonic-clonic seizures. It is also used to treat Lennox-Gastaut syndrome, a rare form of epilepsy. Levetiracetam is part of the Central Nervous System (CNS) drug market, which includes medications used to treat neurological disorders such as epilepsy, Parkinson's disease, and Alzheimer's disease. The CNS drug market is highly competitive, with many different drugs available to treat the same condition. Companies in the Levetiracetam market include UCB, Inc., Sun Pharmaceutical Industries Ltd., Mylan N.V., Dr. Reddy's Laboratories Ltd., and Teva Pharmaceutical Industries Ltd. Show Less Read more